J. Michael McWilliams, MD, PhD, the Warren Alpert Foundation Professor of Health Care Policy at the Blavatnik Institute at Harvard Medical School and an internist at Brigham and Women’s Hospital, discusses hospital readmissions and pay-for-performance measures.
David Y. Ting, chief medical information officer of the Massachusetts General Physicians Organization in Boston and co-director of the MGH Center for Innovation in Digital HealthCare, discusses technologies aimed at easing administrative burden and provider burnout.
Genomic scientist George Church, PhD, professor of Genetics at Harvard Medical School, discusses approaches to genome editing and applications for organoids in drug discovery and development.
Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.
Isaac S. Kohane, MD, PhD, chair of the Department of Biomedical Informatics at Harvard Medical School, discusses promising uses and the path forward for artificial intelligence (AI) in health care.
Leemore S. Dafny, PhD, the Bruce V. Rauner Professor of Business Administration at Harvard Business School, discusses provider consolidation, the CVS-Aetna merger and the potential impact of Big Tech on health care consolidation.
Margaret “Molly” Hayes, MD, associate director of the Internal Medicine Residency Training Program and assistant director of the medical intensive care unit at Beth Israel Deaconess Medical Center (BIDMC), discusses handling uncertainty in critical care decision-making.
Amit V. Khera, MD, MSc, associate director of the Precision Medicine Unit at the Massachusetts General Hospital Center for Genomics Medicine and the Cardiovascular Disease Initiative at the Broad Institute, discusses the potential impact of polygenic scores.
Zirui Song, MD, PhD, an assistant professor of health care policy and medicine at Harvard Medical School and an internal medicine physician at Massachusetts General Hospital, discusses workplace wellness programs.
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
